MLchartDataset catalogue

AD 32

Term · Oncology and biomedicine · MLC-T-ONC-000223

A drug used to treat bladder carcinoma in situ that did not get better after treatment with bacillus Calmette-Guerin (BCG). It is used in patients who cannot have surgery right away to remove all or part of the bladder. AD 32 is given as a solution through a catheter that is placed into the bladder. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. AD 32 is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called valrubicin and Valstar.

Table 1. Record
IdentifierMLC-T-ONC-000223
FieldOncology and biomedicine
Synonymsvalrubicin; Valstar
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000223",
  "term": "AD 32",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat bladder carcinoma in situ that did not get better after treatment with bacillus Calmette-Guerin (BCG). It is used in patients who cannot have surgery right away to remove all or part of the bladder. AD 32 is given as a solution through a catheter that is placed into the bladder. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. AD 32 is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called valrubicin and Valstar.",
  "synonyms": [
    "valrubicin",
    "Valstar"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/ad-32/"
}

Record 352 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.